Bionano Symposium Highlights Optical Genome Mapping's Expanding Role in Oncology and Diagnostics
Event summary
- Bionano Genomics is hosting its annual virtual symposium, Bionano Symposium 2026, from February 23-26, 2026.
- The symposium will feature over 30 researchers from North America, Europe, and Asia presenting on optical genome mapping (OGM) applications.
- Key research areas covered include hematologic malignancies, solid tumors, bioprocessing, constitutional genetic disorders, and gene/cell therapy.
- The event includes scientific presentations, panel discussions, and a virtual poster hall, with sessions beginning at 7:00 AM PST.
The big picture
Bionano's symposium underscores the growing recognition of optical genome mapping as a valuable tool in genomic analysis, particularly for complex disease diagnostics and therapeutic development. While OGM offers advantages in detecting structural variants, its adoption hinges on demonstrating clear clinical utility and cost-effectiveness compared to existing technologies. The event signals Bionano’s continued effort to expand the applications and market reach of its platform within a competitive and evolving genomics landscape.
What we're watching
- Adoption Rate
- The pace at which the showcased applications of OGM translate into broader clinical adoption will be a key indicator of Bionano's long-term success, particularly given the relatively nascent stage of the technology.
- Competitive Landscape
- Whether Bionano can maintain its technological lead and fend off competition from established genomics players offering alternative sequencing methods remains a critical risk factor.
- Workflow Integration
- How effectively Bionano’s tools and software integrate into existing laboratory workflows will determine the ease of adoption and ultimately impact the scalability of OGM implementation.
Related topics